No Data
No Data
Thalys Medical Technology Group (SHSE:603716) Adds CN¥381m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 45%
Improved Revenues Required Before Thalys Medical Technology Group Corporation (SHSE:603716) Stock's 32% Jump Looks Justified
Celi Healthcare: third quarter report 2024
Third Quarter Report 2024
Thalys Medical Technology Group Corporation (603716.SH) released its performance for the first three quarters, with a net loss of 56.0251 million yuan.
Thalys Medical Technology Group Corporation (603716.SH) released its third quarter report for 2024, with a revenue of 14...
thalys medical technology group corporation (603716.SH): a net loss of 56.025 million yuan in the first three quarters.
October 28th, Thalys Medical Technology Group Corporation (603716.SH) released its third quarter report, with revenue of 1.42 billion yuan, a year-on-year decrease of 7.15%, net loss of 56.025 million yuan, non-recurring net loss of 26.11 million yuan, and basic earnings per share of -0.28 yuan.
No Data
No Data